IView Therapeutics is a clinical-stage ophthalmology drug development company with a focus on novel extended-release formulations, combination therapies, and exploring topical applications of new chemical entities or repurposed drugs. Founded in 2015, the company operates in the Biotechnology, Health Care, Health and Wellness, and Medical Devices industries. Based in the United States, IView Therapeutics prides itself on their slogan, "Bright Science. Clear Vision." Currently, there is no public information available regarding their last investment or the involved investors.
There is no investment information
No recent news or press coverage available for IView Therapeutics.